Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence

1Perme MP, Jereb B. Trends in survival after childhood cancer in Slovenia between 1957 and 2007. Pediatr Hematol Oncol 2009; 26: 240-51.PermeMPJerebBTrends in survival after childhood cancer in Slovenia between 1957 and 2007Pediatr Hematol Oncol2009262405110.1080/08880010902900437Search in Google Scholar

2Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova1 RF, et al. Solid tumors in young children in Moscow Region of Russian Federation. Radiol Oncol 2008; 42: 39-44.KachanovDYDobrenkovKVShamanskayaTVAbdullaevRTInushkinaEVSavkova1RFSolid tumors in young children in Moscow Region of Russian FederationRadiol Oncol200842394410.2478/v10019-007-0037-2Search in Google Scholar

3Jazbec J, Ećimović P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574-81.JazbecJEćimovićPJerebBSecond neoplasms after treatment of childhood cancer in SloveniaPediatr Blood Cancer2004425748110.1002/pbc.20025Search in Google Scholar

4Zaletel L, Bratanic N, Jereb B. Gonadal function in patients treated for Hodgkin’s disease in childhood. Radiol Oncol 2010; 44: 87-193.ZaletelLBratanicNJerebBGonadal function in patients treated for Hodgkin’s disease in childhoodRadiol Oncol2010448719310.2478/v10019-010-0034-8Search in Google Scholar

5Doi K, Mieno MN, Shimada Y, Yonehara H, Yoshinaga S. Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy. J Radiat Res 2014; 55: 885-901.DoiKMienoMNShimadaYYoneharaHYoshinagaSMethodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapyJ Radiat Res20145588590110.1093/jrr/rru045Search in Google Scholar

6Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010; 174: 741-52BhattiPVeigaLHRonckersCMSigurdsonAJStovallMSmithSARisk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor studyRadiat Res20101747415210.1667/RR2240.1Search in Google Scholar

7Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005; 365: 2014-23.SigurdsonAJRonckersCMMertensACStovallMSmithSALiuYPrimary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control studyLancet200536520142310.1016/S0140-6736(05)66695-0Search in Google Scholar

8Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91: 4798-804.SadetzkiSChetritALubinaAStovallMNovikovIRisk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitisJ Clin Endocrinol Metab200691479880410.1210/jc.2006-074317018661Search in Google Scholar

9Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003; 97: 2397-403.AcharyaSSarafoglouKLaQuagliaMLindsleySGeraldWWollnerNThyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescenceCancer200397239740310.1002/cncr.1136212733137Search in Google Scholar

10Versteyhe S, Driessens N, Ghaddhab C, Tarabichi M, Hoste C, Dumont JE, et al. Comparative analysis of the thyrocytes and T cells: responses to H2O2 and radiation reveals an H2O2-induced antioxidant transcriptional program in thyrocytes. J Clin Endocrinol Metab 2013; 98: E1645-54.VersteyheSDriessensNGhaddhabCTarabichiMHosteCDumontJEComparative analysis of the thyrocytes and T cells: responses to H2O2 and radiation reveals an H2O2-induced antioxidant transcriptional program in thyrocytesJ Clin Endocrinol Metab201398E16455410.1210/jc.2013-126623666977Search in Google Scholar

11van Loon B, Markkanen E, Hübscher U. Oxygen as a friend and enemy: how to combat the mutational potential of 8-oxo-guanine. DNA Repair 2010; 9: 604-16.van LoonBMarkkanenEHübscherUOxygen as a friend and enemy: how to combat the mutational potential of 8-oxo-guanineDNA Repair201096041610.1016/j.dnarep.2010.03.00420399712Search in Google Scholar

12Karger S, Krause K, Engelhardt C, Weidinger C, Gimm O, Dralle H, et al. Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours. J Mol Endocrinol 2012; 48: 193-202.KargerSKrauseKEngelhardtCWeidingerCGimmODralleHDistinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumoursJ Mol Endocrinol20124819320210.1530/JME-11-011922331172Search in Google Scholar

13Erdamar H, Cimen B, Gülcemal H, Saraymen R, Yerer B, Demirci H. Increased lipid peroxidation and impaired enzymatic antioxidant defence mechanism in thyroid tissue with multinodular goiter and papillary carcinoma. Clin Biochem 2010; 43: 650-4.ErdamarHCimenBGülcemalHSaraymenRYererBDemirciHIncreased lipid peroxidation and impaired enzymatic antioxidant defence mechanism in thyroid tissue with multinodular goiter and papillary carcinomaClin Biochem201043650410.1016/j.clinbiochem.2010.02.00520171198Search in Google Scholar

14Krohn K, Maier J, Paschke R. Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 2007; 3: 713-20.KrohnKMaierJPaschkeRMechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumorsNat Clin Pract Endocrinol Metab200737132010.1038/ncpendmet062117893690Search in Google Scholar

15Karbownik-Lewińska M, Kokoszko-Bilska A. Oxidative damage to macromolecules in the thyroid - experimental evidence. Thyroid Res 2012; 5: 25.Karbownik-LewińskaMKokoszko-BilskaA.Oxidative damage to macromolecules in the thyroid - experimental evidenceThyroid Res201252510.1186/1756-6614-5-25354201723270549Search in Google Scholar

16Xing M. Oxidative stress: a new risk factor for thyroid cancer. Endocr Relat Cancer 2012; 19: 7-11.XingMOxidative stress: a new risk factor for thyroid cancerEndocr Relat Cancer20121971110.1530/ERC-11-0360377892022143496Search in Google Scholar

17Young O, Crotty T, O’Connell R, O’Sullivan J, Curran AJ. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010; 32: 750-6.YoungOCrottyTO’ConnellRO’SullivanJCurranAJLevels of oxidative damage and lipid peroxidation in thyroid neoplasiaHead Neck201032750610.1002/hed.2124719998441Search in Google Scholar

18Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW. Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer 2011; 18: 773-82.WangDFengJFZengPYangYHLuoJYangYWTotal oxidant/antioxidant status in sera of patients with thyroid cancersEndocr Relat Cancer2011187738210.1530/ERC-11-0230323011222002574Search in Google Scholar

19Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S, et al. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cir Bras 2008; 23: 551-4.AkinciMKosovaFCetinBSepiciAAltanNAslanSOxidant/antioxidant balance in patients with thyroid cancerActa Cir Bras200823551410.1590/S0102-86502008000600013Search in Google Scholar

20Banescu C, Trifa AP, Voidazan S, Moldovan VG, Macarie I, Benedek Lazar E, et al. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study. Oxid Med Cell Longev 2014; 2014: 875861.BanescuCTrifaAPVoidazanSMoldovanVGMacarieIBenedek LazarECAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control studyOxid Med Cell Longev2014201487586110.1155/2014/875861424313525436036Search in Google Scholar

21Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, et al. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis. Eur J Cancer.2009; 45: 2874-81.WangSWangFShiXDaiJPengYGuoXAssociation between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysisEur J Cancer20094528748110.1016/j.ejca.2009.04.02419467856Search in Google Scholar

22Janicka A, Szymańska-Pasternak J, Bober J. [Polymorphisms in the oxidative stress-related genes and cancer risk]. [Article in Polish]. Ann Acad Med Stetin 2013; 59: 18-28.JanickaASzymańska-PasternakJBoberJ[Polymorphisms in the oxidative stress-related genes and cancer risk]. [Article in Polish]Ann Acad Med Stetin2013591828Search in Google Scholar

23Lin JC, Kuo WR, Chiang FY, Hsiao PJ, Lee KW, Wu CW, et al. Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 2009; 145: 508-13.LinJCKuoWRChiangFYHsiaoPJLeeKWWuCWGlutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancerSurgery20091455081310.1016/j.surg.2008.12.00819375609Search in Google Scholar

24Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005; 15: 311-9.SuttonAImbertAIgoudjilADescatoireVCazanaveSPessayreDThe manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stabilityPharmacogenet Genomics200515311910.1097/01213011-200505000-0000615864132Search in Google Scholar

25Sun GG, Wang YD, Lu YF, Hu WN. Different association of manganese superoxide dismutase gene polymorphisms with risk of prostate, esophageal, and lung cancers: evidence from a meta-analysis of 20,025 subjects. Asian Pac J Cancer Prev 2013; 14: 1937-43.SunGGWangYDLuYFHuWNDifferent association of manganese superoxide dismutase gene polymorphisms with risk of prostate, esophageal, and lung cancers: evidence from a meta-analysis of 20,025 subjectsAsian Pac J Cancer Prev20131419374310.7314/APJCP.2013.14.3.1937Search in Google Scholar

26Castaldo SA, da Silva AP, Matos A, Inácio A, Bicho M, Medeiros R, et al. The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancer. Tumour Biol 2015; 36: 909-14.CastaldoSAda SilvaAPMatosAInácioABichoMMedeirosRThe role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancerTumour Biol2015369091410.1007/s13277-014-2714-225307973Search in Google Scholar

27Geybels MS, van den Brandt PA, van Schooten FJ, Verhage BA. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2015; 24: 178-86.GeybelsMSvan den BrandtPAvan SchootenFJVerhageBAOxidative stress-related genetic variants pro- and antioxidant intake and status and advanced prostate cancer riskCancer Epidemiol Biomarkers Prev2015241788610.1158/1055-9965.EPI-14-096825315963Search in Google Scholar

28Hong Z, Tian C, Zhang X. GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity and cancer risk. Mol Biol Rep 2013; 40: 1801-12.HongZTianCZhangXGPX1 gene Pro200 Leu polymorphism, erythrocyte GPX activity and cancer riskMol Biol Rep20134018011210.1007/s11033-012-2234-323073788Search in Google Scholar

29Li J, Long J, Hu Y, Tan A, Guo X, Zhang S. Glutathione S-transferase M1, T1, and P1 polymorphisms and thyroid cancer risk: a meta-analysis. Cancer Epidemiol 2012; 36: 333-40.LiJLongJHuYTanAGuoXZhangSGlutathione S-transferase M1, T1, and P1 polymorphisms and thyroid cancer risk: a meta-analysisCancer Epidemiol2012363334010.1016/j.canep.2012.06.00222765906Search in Google Scholar

30Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 229-36.Bohanec GrabarPLogarDTomsicMRozmanBDolzanVGenetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritisClin Exp Rheumatol20092722936Search in Google Scholar

31Zhuo X, Cai L, Xiang Z, Li Q, Zhang X. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res 2009; 28: 46.ZhuoXCaiLXiangZLiQZhangXGSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysisJ Exp Clin Cancer Res2009284610.1186/1756-9966-28-46266905519338664Search in Google Scholar

32Koh WP, Nelson HH, Yuan JM, Van den Berg D, Jin A, Wang R, et al. Glutathione S-transferase (GST) gene polymorphisms, cigarette smoking and colorectal cancer risk among Chinese in Singapore. Carcinogenesis 2011; 32: 1507-11.KohWPNelsonHHYuanJMVan den BergDJinAWangRGlutathione S-transferase (GST) gene polymorphisms cigarette smoking and colorectal cancer risk among Chinese in SingaporeCarcinogenesis20113215071110.1093/carcin/bgr175317942621803734Search in Google Scholar

33Ho T, Zhao C, Zheng R, Liu Z, Wei Q, Sturgis EM. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas. A case control study. Arch Otolaryngol Head Neck Surg 2006; 132: 756-61.HoTZhaoCZhengRLiuZWeiQSturgisEMGlutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas. A case control studyArch Otolaryngol Head Neck Surg20061327566110.1001/archotol.132.7.756Search in Google Scholar

34Lemos MC, Coutinho E, Gomes L, Carrilho F, Rodrigues F, Regateiro FJ, et al. Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer. J Endocrinol Invest 2008; 31: 542-5.LemosMCCoutinhoEGomesLCarrilhoFRodriguesFRegateiroFJCombined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancerJ Endocrinol Invest200831542510.1007/BF03346405Search in Google Scholar

35Gaspar J, Rodrigues S, Gil OM, Manita I, Ferreira TC, Limbert E, et al. Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet Cytogenet 2004; 151: 60-7.GasparJRodriguesSGilOMManitaIFerreiraTCLimbertECombined effects of glutathione S-transferase polymorphisms and thyroid cancer riskCancer Genet Cytogenet200415160710.1016/j.cancergencyto.2003.09.018Search in Google Scholar

36Mertens AC, Mitby PA, Radloff G, Jones IM, Perentesis J, Kiffmeyer WR, et al. XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 2004; 101: 1463-72.MertensACMitbyPARadloffGJonesIMPerentesisJKiffmeyerWRXRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin diseaseCancer200410114637210.1002/cncr.20520Search in Google Scholar

37Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer registry of Republic of Slovenia; 2013.Cancer in Slovenia 2010.LjubljanaInstitute of Oncology Ljubljana Epidemiology and Cancer, Registry Cancer registry of Republic of Slovenia2013Search in Google Scholar

38Jereb B. Model for long-term follow-up of survivors of childhood cancer. Med Pediatr Oncol 2000; 34: 256-8.JerebBModel for long-term follow-up of survivors of childhood cancerMed Pediatr Oncol200034256810.1002/(SICI)1096-911X(200004)34:4<256::AID-MPO5>3.0.CO;2-8Search in Google Scholar

39Tatar IG, Kurt A, Yilmaz KB, Doğan M, Hekimoglu B, Hucumenoglu S. The role of elastosonography, gray-scale and colour flow Doppler sonography in prediction of malignancy in thyroid nodules. Radiol Oncol 2014; 48: 348-53.TatarIGKurtAYilmazKBDoğanMHekimogluBHucumenogluSThe role of elastosonography gray-scale and colour flow Doppler sonography in prediction of malignancy in thyroid nodulesRadiol Oncol2014483485310.2478/raon-2014-0007Search in Google Scholar

40Goricar K, Kovac V, Jazbec J, Lamovec J, Dolzan V. Homologous recombination repair polymorphisms and the risk for osteosarcoma. J Med Biochem 2014; 33: 1-8.GoricarKKovacVJazbecJLamovecJDolzanVHomologous recombination repair polymorphisms and the risk for osteosarcomaJ Med Biochem20143318Search in Google Scholar

41Jazbec J, Aplenc R, Dolzan V, Debeljak M, Jereb B. GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia. Leukemia 2003; 17: 2540-2.JazbecJAplencRDolzanVDebeljakMJerebBGST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemiaLeukemia2003172540210.1038/sj.leu.2403164Search in Google Scholar

42Erculj N, Zadel M, Dolzan V. Genetic polymorphisms in base excision repair in healthy slovenian population and their influence on DNA damage. Acta Chim Slov 2010; 57: 182-8.ErculjNZadelMDolzanVGenetic polymorphisms in base excision repair in healthy slovenian population and their influence on DNA damageActa Chim Slov2010571828Search in Google Scholar

43Goricar K, Erculj N, Zadel M, Dolzan V. Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage. Radiol Oncol 2012; 46:46-53.GoricarKErculjNZadelMDolzanVGenetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damageRadiol Oncol201246465310.2478/v10019-012-0001-7Search in Google Scholar

44Guo S, Thompson E. Performing the exact test of Hardy–Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-72.GuoSThompsonEPerforming the exact test of Hardy–Weinberg proportion for multiple allelesBiometrics1992483617210.2307/2532296Search in Google Scholar

45Cao M, Mu X, Jiang C, Yang G, Chen H, Xue W. Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis. Tumour Biol 2014; 35: 759-64.CaoMMuXJiangCYangGChenHXueWSingle-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysisTumour Biol2014357596410.1007/s13277-013-1103-6Search in Google Scholar

46Saadat M, Saadat S. Genetic polymorphism of CAT C-262 T and susceptibility to breast cancer, a case-control study and meta-analysis of the literature. Pathol Oncol Res 2015; 21: 433-7.SaadatMSaadatSGenetic polymorphism of CAT C-262 T and susceptibility to breast cancer a case-control study and meta-analysis of the literaturePathol Oncol Res201521433710.1007/s12253-014-9840-425248722Search in Google Scholar